Mortality Risk Associated With Truncating Founder Mutations in Titin

Mark Jansen, Annette F. Baas, Karin Y. van Spaendonck-Zwarts, Amber S. Ummels, Arthur van den Wijngaard, Jan D. H. Jongbloed, Marjon A. van Slegtenhorst, Ronald H. Lekanne Deprez, Marja W. Wessels, Michelle Michels, Arjan C. Houweling, Edgar T. Hoorntje, Paula J. T. M. Helderman-van den Enden, Daniela Q. C. M. Barge-Schaapveld, J. Peter van Tintelen, Maarten P. van den Berg, Arthur A. M. Wilde, Hans K. Ploos van Amstel, Eric A. M. Hennekam, Folkert W. AsselbergsEric J. G. Sijbrands, Dennis Dooijes*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number002436
Number of pages8
JournalCirculation: Genomic and Precision Medicine
Volume12
Issue number5
DOIs
Publication statusPublished - May 2019

Keywords

  • cardiomyopathy
  • dilated
  • mortality
  • mutation
  • natural history
  • titin
  • DILATED CARDIOMYOPATHY
  • HEART-FAILURE
  • VARIANTS
  • GENETICS
  • LONG
  • FORM

Cite this

Jansen, M., Baas, A. F., van Spaendonck-Zwarts, K. Y., Ummels, A. S., van den Wijngaard, A., Jongbloed, J. D. H., van Slegtenhorst, M. A., Deprez, R. H. L., Wessels, M. W., Michels, M., Houweling, A. C., Hoorntje, E. T., Helderman-van den Enden, P. J. T. M., Barge-Schaapveld, D. Q. C. M., van Tintelen, J. P., van den Berg, M. P., Wilde, A. A. M., van Amstel, H. K. P., Hennekam, E. A. M., ... Dooijes, D. (2019). Mortality Risk Associated With Truncating Founder Mutations in Titin. Circulation: Genomic and Precision Medicine, 12(5), [002436]. https://doi.org/10.1161/CIRCGEN.118.002436